| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | 7.50e-08 | 41 | 106 | 6 | GO:0008227 | |
| GeneOntologyMolecularFunction | adrenergic receptor activity | 1.54e-07 | 10 | 106 | 4 | GO:0004935 | |
| GeneOntologyMolecularFunction | beta-adrenergic receptor activity | 5.79e-07 | 4 | 106 | 3 | GO:0004939 | |
| GeneOntologyMolecularFunction | transporter activity | CACNA1A MPV17 ATP8B3 ANO9 ABCA2 ATP9B SLC46A1 SLC34A3 ATP13A2 SLC29A2 SLC9C2 ABCC6 SLC6A2 PIEZO2 SLC6A5 OSBPL10 CTNS GABRA1 | 1.42e-04 | 1289 | 106 | 18 | GO:0005215 |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 1.55e-04 | 51 | 106 | 4 | GO:0140303 | |
| GeneOntologyMolecularFunction | norepinephrine binding | 1.66e-04 | 4 | 106 | 2 | GO:0051380 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR2AK2 HTR4 HTR7 GPRC5C OR2J2 GPRC5A PTH2R ADRA1D ADRB1 ADRB2 ADRB3 RXFP2 CCR4 TAS2R60 | 2.40e-04 | 884 | 106 | 14 | GO:0004930 |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 4.32e-04 | 28 | 106 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 4.33e-04 | 119 | 106 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | peptidase activity | OVCH2 RHBDL1 CPA3 USP9Y ATXN3L TGM2 MMEL1 PAN2 MMP1 CTSE MMP19 | 7.10e-04 | 654 | 106 | 11 | GO:0008233 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR2AK2 HTR4 HTR7 HLA-DRB1 GPRC5C OR2J2 GPRC5A PTH2R ADRA1D ADRB1 ADRB2 PTPRB ADRB3 RXFP2 CCR4 TAS2R60 GABRA1 | 7.50e-04 | 1353 | 106 | 17 | GO:0004888 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCA2 SLC46A1 SLC34A3 ATP13A2 SLC9C2 ABCC6 SLC6A2 SLC6A5 CTNS | 9.95e-04 | 477 | 106 | 9 | GO:0022804 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 1.13e-03 | 301 | 106 | 7 | GO:0022853 | |
| GeneOntologyMolecularFunction | symporter activity | 1.23e-03 | 150 | 106 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1A MPV17 ANO9 ABCA2 SLC46A1 SLC34A3 ATP13A2 SLC29A2 SLC9C2 ABCC6 SLC6A2 PIEZO2 SLC6A5 CTNS GABRA1 | 1.40e-03 | 1180 | 106 | 15 | GO:0022857 |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by norepinephrine-epinephrine | 4.37e-08 | 8 | 105 | 4 | GO:0001993 | |
| GeneOntologyBiologicalProcess | norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure | 1.28e-07 | 3 | 105 | 3 | GO:0002025 | |
| GeneOntologyBiologicalProcess | positive regulation of blood pressure by epinephrine-norepinephrine | 4.42e-06 | 7 | 105 | 3 | GO:0003321 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating adrenergic receptor signaling pathway | 7.39e-06 | 25 | 105 | 4 | GO:0071880 | |
| GeneOntologyBiologicalProcess | sodium ion transport | SLC34A3 NKAIN2 SLC9C2 ARF1 SLC6A2 ADRB2 NKAIN4 SLC6A5 NKAIN1 | 1.15e-05 | 275 | 105 | 9 | GO:0006814 |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure mediated by a chemical signal | 1.47e-05 | 61 | 105 | 5 | GO:0003044 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1A TCAF2 ANO9 HTR7 SLC46A1 SLC34A3 NKAIN2 ATP13A2 SLC9C2 ABCC6 ARF1 SLC6A2 PIEZO2 ADRB1 ADRB2 NKAIN4 SLC6A5 NKAIN1 CTNS GABRA1 | 1.74e-05 | 1374 | 105 | 20 | GO:0006811 |
| GeneOntologyBiologicalProcess | negative regulation of systemic arterial blood pressure | 2.04e-05 | 32 | 105 | 4 | GO:0003085 | |
| GeneOntologyBiologicalProcess | adrenergic receptor signaling pathway | 2.94e-05 | 35 | 105 | 4 | GO:0071875 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 5.54e-05 | 191 | 105 | 7 | GO:0007189 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | 6.63e-05 | 344 | 105 | 9 | GO:0003018 | |
| GeneOntologyBiologicalProcess | diet induced thermogenesis | 8.28e-05 | 17 | 105 | 3 | GO:0002024 | |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organism growth | 8.28e-05 | 17 | 105 | 3 | GO:0040015 | |
| GeneOntologyBiologicalProcess | lipid homeostasis | 1.03e-04 | 211 | 105 | 7 | GO:0055088 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 1.08e-04 | 286 | 105 | 8 | GO:0007188 | |
| GeneOntologyBiologicalProcess | oxidative stress-induced premature senescence | 1.53e-04 | 4 | 105 | 2 | GO:0090403 | |
| GeneOntologyBiologicalProcess | positive regulation of the force of heart contraction by epinephrine-norepinephrine | 1.53e-04 | 4 | 105 | 2 | GO:0001997 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1A TCAF2 ANO9 SLC46A1 SLC34A3 ATP13A2 SLC9C2 ABCC6 ARF1 SLC6A2 PIEZO2 ADRB1 ADRB2 SLC6A5 CTNS GABRA1 | 1.59e-04 | 1115 | 105 | 16 | GO:0034220 |
| GeneOntologyBiologicalProcess | regulation of sodium ion transport | 1.67e-04 | 101 | 105 | 5 | GO:0002028 | |
| GeneOntologyBiologicalProcess | organophosphate ester transport | 1.81e-04 | 162 | 105 | 6 | GO:0015748 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | CACNA1A TLCD3B ABCA2 HLA-DRB1 COX10 SLC46A1 GCKR SLC34A3 ATP13A2 SLC9C2 ABCC6 ARF1 TGM2 ADRB1 CTNS G6PC1 TLCD3A | 1.83e-04 | 1249 | 105 | 17 | GO:0048878 |
| GeneOntologyBiologicalProcess | heat generation | 2.11e-04 | 23 | 105 | 3 | GO:0031649 | |
| GeneOntologyBiologicalProcess | lipid translocation | 2.48e-04 | 60 | 105 | 4 | GO:0034204 | |
| GeneOntologyBiologicalProcess | positive regulation of blood-brain barrier permeability | 2.54e-04 | 5 | 105 | 2 | GO:1905605 | |
| GeneOntologyBiologicalProcess | positive regulation of the force of heart contraction by chemical signal | 2.54e-04 | 5 | 105 | 2 | GO:0003099 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 3.38e-04 | 65 | 105 | 4 | GO:0097035 | |
| GeneOntologyBiologicalProcess | import into cell | CACNA1A HSPG2 ABCA2 ATP9B SLC46A1 SLC29A2 SLC9C2 ARF1 SLC6A2 TGM2 PLA2R1 ADRB1 ADRB2 ADRB3 SLC6A5 | 3.48e-04 | 1074 | 105 | 15 | GO:0098657 |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure | 4.33e-04 | 124 | 105 | 5 | GO:0003073 | |
| GeneOntologyBiologicalProcess | negative regulation of blood pressure | 4.49e-04 | 70 | 105 | 4 | GO:0045776 | |
| Domain | ADR_fam | 1.32e-09 | 10 | 106 | 5 | IPR002233 | |
| Domain | NKAIN | 7.08e-07 | 4 | 106 | 3 | PF05640 | |
| Domain | Na/K-Atpase_Interacting | 7.08e-07 | 4 | 106 | 3 | IPR008516 | |
| Domain | MAGEA3/MAGEA6 | 3.19e-05 | 2 | 106 | 2 | IPR030097 | |
| Domain | 7TM_GPCR_Srsx | 4.26e-05 | 112 | 106 | 6 | SM01381 | |
| Domain | ZO | 9.54e-05 | 3 | 106 | 2 | IPR005417 | |
| Domain | ARF | 5.83e-04 | 29 | 106 | 3 | PS51417 | |
| Domain | Small_GTPase_ARF | 5.83e-04 | 29 | 106 | 3 | IPR024156 | |
| Domain | Arf | 7.11e-04 | 31 | 106 | 3 | PF00025 | |
| Domain | - | 7.82e-04 | 32 | 106 | 3 | 3.40.1110.10 | |
| Domain | - | 7.82e-04 | 32 | 106 | 3 | 2.70.150.10 | |
| Domain | Small_GTPase_ARF/SAR | 8.57e-04 | 33 | 106 | 3 | IPR006689 | |
| Domain | LAMININ_IVA | 8.74e-04 | 8 | 106 | 2 | PS51115 | |
| Domain | Laminin_B | 8.74e-04 | 8 | 106 | 2 | PF00052 | |
| Domain | LamB | 8.74e-04 | 8 | 106 | 2 | SM00281 | |
| Domain | Laminin_IV | 8.74e-04 | 8 | 106 | 2 | IPR000034 | |
| Domain | ATPase_P-typ_cyto_domN | 1.02e-03 | 35 | 106 | 3 | IPR023299 | |
| Domain | P_typ_ATPase | 1.11e-03 | 36 | 106 | 3 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 1.11e-03 | 36 | 106 | 3 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 1.11e-03 | 36 | 106 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.20e-03 | 37 | 106 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.20e-03 | 37 | 106 | 3 | PF00122 | |
| Domain | Spy1 | 1.70e-03 | 11 | 106 | 2 | PF11357 | |
| Domain | Laminin_G_1 | 1.70e-03 | 11 | 106 | 2 | PF00054 | |
| Domain | Speedy | 1.70e-03 | 11 | 106 | 2 | IPR020984 | |
| Domain | P_typ_ATPase_c | 2.78e-03 | 14 | 106 | 2 | IPR032630 | |
| Domain | P-type_ATPase_N | 2.78e-03 | 14 | 106 | 2 | IPR032631 | |
| Domain | P-type_ATPase_IV | 2.78e-03 | 14 | 106 | 2 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 2.78e-03 | 14 | 106 | 2 | PF16212 | |
| Domain | PhoLip_ATPase_N | 2.78e-03 | 14 | 106 | 2 | PF16209 | |
| Domain | - | ABCA2 SAMD9 ABCC6 NLRC4 ARF1 ARF3 ARF5 TJP1 TJP2 HS3ST4 DNAH5 | 3.40e-03 | 746 | 106 | 11 | 3.40.50.300 |
| Domain | TLC | 3.64e-03 | 16 | 106 | 2 | PS50922 | |
| Domain | TLC | 3.64e-03 | 16 | 106 | 2 | SM00724 | |
| Domain | TRAM_LAG1_CLN8 | 3.64e-03 | 16 | 106 | 2 | PF03798 | |
| Domain | TLC-dom | 3.64e-03 | 16 | 106 | 2 | IPR006634 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 4.60e-03 | 18 | 106 | 2 | PS00754 | |
| Domain | Pept_M10A_stromelysin-type | 4.60e-03 | 18 | 106 | 2 | IPR016293 | |
| Domain | GPCR_Rhodpsn_7TM | 4.77e-03 | 670 | 106 | 10 | IPR017452 | |
| Domain | SNF | 5.12e-03 | 19 | 106 | 2 | PF00209 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 5.12e-03 | 19 | 106 | 2 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 5.12e-03 | 19 | 106 | 2 | PS50267 | |
| Domain | Na/ntran_symport | 5.12e-03 | 19 | 106 | 2 | IPR000175 | |
| Domain | 7tm_1 | 5.13e-03 | 677 | 106 | 10 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 5.56e-03 | 685 | 106 | 10 | PS00237 | |
| Domain | Semaphorin | 5.67e-03 | 20 | 106 | 2 | IPR027231 | |
| Domain | PG_binding_1 | 5.67e-03 | 20 | 106 | 2 | PF01471 | |
| Domain | MAGE_N | 5.67e-03 | 20 | 106 | 2 | SM01392 | |
| Domain | Peptidoglycan-bd-like | 5.67e-03 | 20 | 106 | 2 | IPR002477 | |
| Domain | - | 5.76e-03 | 64 | 106 | 3 | 3.40.50.1000 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 5.90e-03 | 691 | 106 | 10 | PS50262 | |
| Domain | GPCR_Rhodpsn | 5.96e-03 | 692 | 106 | 10 | IPR000276 | |
| Domain | GPCR_3 | 6.25e-03 | 21 | 106 | 2 | IPR000337 | |
| Domain | 7tm_3 | 6.84e-03 | 22 | 106 | 2 | PF00003 | |
| Domain | MAGE_N | 6.84e-03 | 22 | 106 | 2 | PF12440 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 6.84e-03 | 22 | 106 | 2 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 6.84e-03 | 22 | 106 | 2 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 6.84e-03 | 22 | 106 | 2 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 6.84e-03 | 22 | 106 | 2 | PS50259 | |
| Domain | GPCR_3_C | 6.84e-03 | 22 | 106 | 2 | IPR017978 | |
| Pathway | WP_MONOAMINE_GPCRS | 2.27e-08 | 31 | 83 | 6 | MM15871 | |
| Pathway | WP_MONOAMINE_GPCRS | 3.38e-08 | 33 | 83 | 6 | M39585 | |
| Pathway | REACTOME_ADRENOCEPTORS | 1.38e-07 | 9 | 83 | 4 | M27302 | |
| Pathway | REACTOME_ADRENOCEPTORS | 1.38e-07 | 9 | 83 | 4 | MM15009 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 1.54e-07 | 42 | 83 | 6 | M5868 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 1.54e-07 | 42 | 83 | 6 | MM14971 | |
| Pathway | WP_GPCRS_NONODORANT | 3.50e-06 | 266 | 83 | 10 | MM15843 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 2.08e-05 | 143 | 83 | 7 | MM15055 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 3.07e-05 | 272 | 83 | 9 | M13380 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 3.80e-05 | 157 | 83 | 7 | M4904 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | HTR4 HTR7 PTH2R ADRA1D ADRB1 ADRB2 ADRB3 WNT16 RXFP2 CCR4 TAS2R60 | 8.14e-05 | 463 | 83 | 11 | M507 |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 8.42e-05 | 178 | 83 | 7 | M2890 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP8B3 ANO9 ABCA2 ATP9B SLC46A1 SLC34A3 ATP13A2 SLC29A2 SLC9C2 ABCC6 ARF1 SLC6A2 SLC6A5 CTNS | 9.12e-05 | 736 | 83 | 14 | M27287 |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 1.04e-04 | 16 | 83 | 3 | M39849 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.11e-04 | 186 | 83 | 7 | MM15994 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.44e-04 | 260 | 83 | 8 | M39397 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP8B3 ANO9 ABCA2 ATP9B SLC46A1 SLC34A3 ATP13A2 SLC29A2 ABCC6 ARF1 SLC6A2 SLC6A5 CTNS | 1.62e-04 | 681 | 83 | 13 | MM14985 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 2.09e-04 | 430 | 83 | 10 | MM15160 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 7.11e-04 | 330 | 83 | 8 | M18334 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 7.54e-04 | 333 | 83 | 8 | MM14963 | |
| Pubmed | 2.33e-09 | 70 | 108 | 7 | 12036966 | ||
| Pubmed | Adrenergic regulation of AMP-activated protein kinase in brown adipose tissue in vivo. | 1.09e-08 | 9 | 108 | 4 | 21209093 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 18801900 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 28752049 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 24885710 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 15479221 | ||
| Pubmed | betaAR signaling required for diet-induced thermogenesis and obesity resistance. | 2.91e-08 | 3 | 108 | 3 | 12161655 | |
| Pubmed | Role of β-adrenoceptors in glucose uptake in astrocytes using β-adrenoceptor knockout mice. | 2.91e-08 | 3 | 108 | 3 | 21138422 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 26566631 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 23473322 | ||
| Pubmed | Norepinephrine induces lipolysis in beta1/beta2/beta3-adrenoceptor knockout mice. | 2.91e-08 | 3 | 108 | 3 | 15939797 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 17345787 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 16767221 | ||
| Pubmed | Expression and functional role of beta-adrenoceptors in the human urinary bladder urothelium. | 2.91e-08 | 3 | 108 | 3 | 18311486 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 11737201 | ||
| Pubmed | Diverse evolutionary histories for beta-adrenoreceptor genes in humans. | 2.91e-08 | 3 | 108 | 3 | 19576569 | |
| Pubmed | Expression of beta adrenergic receptors in mouse oocytes and preimplantation embryos. | 2.91e-08 | 3 | 108 | 3 | 15791602 | |
| Pubmed | Total beta-adrenoceptor deficiency results in cardiac hypotrophy and negative inotropy. | 2.91e-08 | 3 | 108 | 3 | 20406048 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 7738011 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 23133676 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 15079793 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 15932670 | ||
| Pubmed | Trp64Arg polymorphism in ADRB3 gene is associated with elite endurance performance. | 2.91e-08 | 3 | 108 | 3 | 19553224 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 34483955 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 18239290 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 15464701 | ||
| Pubmed | Control of 4E-BP1 expression in mouse brown adipose tissue by the beta3-adrenoceptor. | 2.91e-08 | 3 | 108 | 3 | 15474034 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 19420258 | ||
| Pubmed | [Association of beta-adrenoceptor gene polymorphism with resting heart rate]. | 2.91e-08 | 3 | 108 | 3 | 17591269 | |
| Pubmed | A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. | 2.91e-08 | 3 | 108 | 3 | 11854867 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 15833937 | ||
| Pubmed | Expression of β-adrenergic receptor subtypes in human normal and dilated ureter. | 2.91e-08 | 3 | 108 | 3 | 28756611 | |
| Pubmed | Association of beta-adrenoceptor single nucleotide polymorphisms with resting heart rate. | 2.91e-08 | 3 | 108 | 3 | 17270896 | |
| Pubmed | Cardiovascular and metabolic alterations in mice lacking both beta1- and beta2-adrenergic receptors. | 2.91e-08 | 3 | 108 | 3 | 10358009 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 12387862 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 21366703 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 15917856 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 29715048 | ||
| Pubmed | Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations. | 1.16e-07 | 4 | 108 | 3 | 17512307 | |
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 18331634 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 20203292 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 18625943 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 9305915 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 29123236 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 27206969 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 17446185 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 20144152 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 21976502 | ||
| Pubmed | Adrenoceptor-related decrease in serum triglycerides is independent of PPARα activation. | 1.16e-07 | 4 | 108 | 3 | 31230416 | |
| Pubmed | Vagal tone dominates autonomic control of mouse heart rate at thermoneutrality. | 1.16e-07 | 4 | 108 | 3 | 18245567 | |
| Pubmed | Physiological consequences of beta-adrenergic receptor disruption. | 1.16e-07 | 4 | 108 | 3 | 9826121 | |
| Pubmed | 2.24e-07 | 200 | 108 | 8 | 18240029 | ||
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 9038142 | ||
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 26132918 | ||
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 16876797 | ||
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 28724789 | ||
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 20831043 | ||
| Pubmed | The central melanocortin system directly controls peripheral lipid metabolism. | 2.90e-07 | 5 | 108 | 3 | 17885689 | |
| Pubmed | ADP-ribosylation factor is functionally and physically associated with the Golgi complex. | 2.90e-07 | 5 | 108 | 3 | 2105501 | |
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 12442007 | ||
| Pubmed | GDF15 promotes weight loss by enhancing energy expenditure in muscle. | 2.90e-07 | 5 | 108 | 3 | 37380764 | |
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 2154750 | ||
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 29589323 | ||
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 29514069 | ||
| Pubmed | Leptin engages a hypothalamic neurocircuitry to permit survival in the absence of insulin. | 5.78e-07 | 6 | 108 | 3 | 24011077 | |
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 20044737 | ||
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 12184796 | ||
| Pubmed | PKC-alpha regulates cardiac contractility and propensity toward heart failure. | 1.01e-06 | 7 | 108 | 3 | 14966518 | |
| Pubmed | 1.01e-06 | 7 | 108 | 3 | 20705341 | ||
| Pubmed | 1.01e-06 | 7 | 108 | 3 | 18694395 | ||
| Pubmed | 1.01e-06 | 7 | 108 | 3 | 28918935 | ||
| Pubmed | 1.01e-06 | 7 | 108 | 3 | 11950392 | ||
| Pubmed | A novel family of transmembrane proteins interacting with beta subunits of the Na,K-ATPase. | 1.01e-06 | 7 | 108 | 3 | 17606467 | |
| Pubmed | 1.01e-06 | 7 | 108 | 3 | 36243005 | ||
| Pubmed | 1.61e-06 | 8 | 108 | 3 | 8947846 | ||
| Pubmed | Cardiac function in genetically engineered mice with altered adrenergic receptor signaling. | 1.61e-06 | 8 | 108 | 3 | 9139936 | |
| Pubmed | 1.61e-06 | 8 | 108 | 3 | 8195219 | ||
| Pubmed | A Stat6/Pten Axis Links Regulatory T Cells with Adipose Tissue Function. | 1.61e-06 | 8 | 108 | 3 | 28877454 | |
| Pubmed | Three-dimensional volume fluorescence-imaging of vascular plasticity in adipose tissues. | 1.61e-06 | 8 | 108 | 3 | 29914852 | |
| Pubmed | 2.41e-06 | 9 | 108 | 3 | 19056576 | ||
| Pubmed | Origin and Function of Stress-Induced IL-6 in Murine Models. | 3.44e-06 | 10 | 108 | 3 | 32610084 | |
| Pubmed | 3.44e-06 | 10 | 108 | 3 | 17383306 | ||
| Pubmed | Brown adipocyte ATF4 activation improves thermoregulation and systemic metabolism. | 3.44e-06 | 10 | 108 | 3 | 34551310 | |
| Pubmed | 3.44e-06 | 10 | 108 | 3 | 10828067 | ||
| Pubmed | 4.66e-06 | 300 | 108 | 8 | 19086053 | ||
| Pubmed | 4.72e-06 | 11 | 108 | 3 | 19779464 | ||
| Pubmed | 6.28e-06 | 12 | 108 | 3 | 30631079 | ||
| Pubmed | Brain motor and fear circuits regulate leukocytes during acute stress. | 8.14e-06 | 13 | 108 | 3 | 35636458 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 18534365 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 22028912 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 17667029 | ||
| Pubmed | Enriched environment enhances β-adrenergic signaling to prevent microglia inflammation by amyloid-β. | 9.55e-06 | 2 | 108 | 2 | 30093491 | |
| Pubmed | Anti-β-adrenoceptors autoimmunity causing 'idiopathic' arrhythmias and cardiomyopathy. | 9.55e-06 | 2 | 108 | 2 | 22447021 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 31107911 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 2474826 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 23318885 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 26888112 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 22593095 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 29587766 | ||
| Pubmed | Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer. | 9.55e-06 | 2 | 108 | 2 | 22038115 | |
| GeneFamily | Adrenoceptors | 5.11e-08 | 9 | 83 | 4 | 169 | |
| GeneFamily | Na+/K+ transporting ATPase interacting | 3.72e-07 | 4 | 83 | 3 | 659 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 3.82e-04 | 31 | 83 | 3 | 357 | |
| GeneFamily | G protein-coupled receptors, Class C orphans | 4.31e-04 | 7 | 83 | 2 | 285 | |
| GeneFamily | TLC domain containing | 9.15e-04 | 10 | 83 | 2 | 1374 | |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 1.57e-03 | 13 | 83 | 2 | 170 | |
| GeneFamily | ATPase phospholipid transporting | 2.10e-03 | 15 | 83 | 2 | 1210 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 3.75e-03 | 20 | 83 | 2 | 736 | |
| GeneFamily | Claudins | 4.95e-03 | 23 | 83 | 2 | 488 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 5.38e-03 | 24 | 83 | 2 | 891 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 6.30e-03 | 26 | 83 | 2 | 904 | |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER | 2.99e-06 | 25 | 106 | 4 | M47986 | |
| Coexpression | GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_DN | 1.75e-05 | 200 | 106 | 7 | M3047 | |
| Coexpression | SMID_BREAST_CANCER_BASAL_DN | MON2 CYP4B1 STK32B RHBDL1 CPA3 GPRC5C GPRC5A ABCC6 PIEZO2 PAN2 POLD4 NKAIN1 | 2.63e-05 | 699 | 106 | 12 | M4960 |
| Coexpression | BMI1_DN.V1_UP | 3.02e-05 | 147 | 106 | 6 | M2782 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-07 | 169 | 106 | 7 | 87116c33c5ca8cb1862e103e5607b1df4d264569 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.66e-07 | 169 | 106 | 7 | cd16e8462ee09877be962fbd9a3badcb825820b0 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-07 | 194 | 106 | 7 | f159ef8541d75a4e98468947f231bb463bec922c | |
| ToppCell | P28|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.10e-06 | 168 | 106 | 6 | 4ee59a6147bbe7e4a03cc2d6fe9d6c10b18a3a06 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-06 | 183 | 106 | 6 | ebe369dc80c4fbf8f4dbe947147f8c47507ffb60 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-sinusoidal_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.57e-06 | 186 | 106 | 6 | e8ead5634686ebaa6a230eea69795d923ce9939d | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.57e-06 | 186 | 106 | 6 | ea936e66ae4b7b40564711fad60ac0137327995f | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.57e-06 | 186 | 106 | 6 | 02fbb02c495e7d64c4ab50e42e5197782f2c0816 | |
| ToppCell | droplet-Lung-3m-Endothelial-venous_endothelial-vein_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.75e-06 | 187 | 106 | 6 | 3827fa80e558b642f3e0036f5ee1a8b69f437e30 | |
| ToppCell | droplet-Lung-3m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.75e-06 | 187 | 106 | 6 | 1bf696eb03422ea507d3efe58dda1d442a65225d | |
| ToppCell | droplet-Lung-3m-Endothelial-venous_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.75e-06 | 187 | 106 | 6 | ebe4d1216cc0d4c079b413d5a5460cfd3a4af922 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-06 | 187 | 106 | 6 | a0bd2b0ec9e73521c245037b1dd51ff8cf24cbf5 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-06 | 187 | 106 | 6 | f2af79a20438108c814a73f9e24cd986d537237f | |
| ToppCell | 367C-Epithelial_cells-Epithelial-H_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.93e-06 | 188 | 106 | 6 | 61422c7919ca0ea02d6be4302f11b169a3ce35e5 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-H_(AT1)|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.93e-06 | 188 | 106 | 6 | 18698f0b22ccbc2b93759acc1c8dbdb30a6b5a16 | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.30e-06 | 190 | 106 | 6 | 52213cd2a6a20772d4f49ba9ac0407abafa528db | |
| ToppCell | facs-Thymus-Epithelium-3m-Endothelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 191 | 106 | 6 | 6676ef9aeb890668cb69e67865404061b8467c25 | |
| ToppCell | facs-Thymus-Epithelium-3m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 191 | 106 | 6 | a157cee0fbc9dce64308128c3578e7327fa178b7 | |
| ToppCell | facs-Thymus-Epithelium-3m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 191 | 106 | 6 | d2311a5b0cf186839000f9f272b6fbc2270ddb44 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-06 | 192 | 106 | 6 | be75783d9578974b662e1cb13bd3442a921fd50a | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-06 | 192 | 106 | 6 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-06 | 192 | 106 | 6 | 4fc98f30f8e738816cd93101fbe8ac40889e302a | |
| ToppCell | B_cells-Activate_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.89e-06 | 193 | 106 | 6 | b6da81920cf2e55f87ec8d4b2b5530cbf7ba2155 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-06 | 195 | 106 | 6 | cad21edd90bf3e2fefdf5773a59cb1a664a69ddd | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-06 | 195 | 106 | 6 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.97e-06 | 198 | 106 | 6 | 122215d9288533ad03562cf777e846504863df9a | |
| ToppCell | 10x5'v1-week_12-13-Endothelial|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.97e-06 | 198 | 106 | 6 | 307dd09e6bc820a148f3000f18dae7aedba4be0b | |
| ToppCell | facs-Lung-18m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.20e-06 | 199 | 106 | 6 | c11e0044d3cc37f6bb26df033ad4448b419addfc | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.79e-05 | 135 | 106 | 5 | e908aacb72a8c340f06cf5b4a6b70c2faac4d027 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 2.79e-05 | 148 | 106 | 5 | db046a02a00829910bf9d7dbda068e730aa78f00 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-05 | 149 | 106 | 5 | 48fca6ae33d7722c024b43ce04f4dbce7b6b424b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-05 | 150 | 106 | 5 | 322aa0c3fc159a4b2897daac881dfc744b24ffc4 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-05 | 152 | 106 | 5 | 7e686721b95c837f2b0d5116927c8ecacef055ee | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Six3-Inhibitory_Neuron.Gad1Gad2.Six3-Pvalb_(Thalamic_reticular_nucleus,_TRN+)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.28e-05 | 76 | 106 | 4 | 14350e0e8fc43531f33f6ed4e583e94a13d1dde5 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Six3-Inhibitory_Neuron.Gad1Gad2.Six3-Pvalb_(Thalamic_reticular_nucleus,_TRN+)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.28e-05 | 76 | 106 | 4 | 539f0076d0571be049c35541a3b281f86ddbecd6 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Six3|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.28e-05 | 76 | 106 | 4 | 492cdcbc577a9334af8e4ded469da17bc7e79025 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 154 | 106 | 5 | 1e32969bee810adaf2d560f0824a16227df513d8 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 155 | 106 | 5 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.17e-05 | 161 | 106 | 5 | f4f5d6eaa32169de699c8ff8e8ae35179c8e25c0 | |
| ToppCell | Club_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 4.17e-05 | 161 | 106 | 5 | 342f5c61d37df61b35c18f5d258043a8f5cef629 | |
| ToppCell | TCGA-Lung-Solid_Tissue_Normal|TCGA-Lung / Sample_Type by Project: Shred V9 | 4.83e-05 | 166 | 106 | 5 | a8ebdd3cb7f59b3feeaacda45ce6d40d10db556f | |
| ToppCell | TCGA-Lung-Solid_Tissue_Normal-Lung|TCGA-Lung / Sample_Type by Project: Shred V9 | 4.83e-05 | 166 | 106 | 5 | c64971c27cb445dffc5a636d4b6a60261b93a2db | |
| ToppCell | TCGA-Lung-Solid_Tissue_Normal-Lung-Lung_normal_tissue|TCGA-Lung / Sample_Type by Project: Shred V9 | 4.83e-05 | 166 | 106 | 5 | 2f3072a7af048f184d33065fdd36153fd563155a | |
| ToppCell | TCGA-Lung-Solid_Tissue_Normal-Lung-Lung_normal_tissue-6|TCGA-Lung / Sample_Type by Project: Shred V9 | 4.83e-05 | 166 | 106 | 5 | 188f2575511f418216874aed9118aa6f165252cb | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-05 | 167 | 106 | 5 | a35ace2c722936d2a3e1f0826e5b6ec6b1340d2b | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.09e-05 | 85 | 106 | 4 | 642755ed2b562dd5e599a04a2b9730e8d29aefe8 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.09e-05 | 85 | 106 | 4 | 2429bacccd103e5b2414264b4aff3103ed9d7cec | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.11e-05 | 168 | 106 | 5 | 6db453cbbbaf4144a86fadcfa5805d33396713b5 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.26e-05 | 169 | 106 | 5 | 41ad349806b279fbe1374b7e3cc7f146a11adb44 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-05 | 169 | 106 | 5 | d18b823836ca6fba79a2d2f10cb9966fa2623af2 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-05 | 169 | 106 | 5 | befb9b1618ea30fbf8983bcc493853da53b809c3 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.26e-05 | 169 | 106 | 5 | 42782c61592742190ab0cba8a94f8bdf9c278f90 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-05 | 172 | 106 | 5 | 7fb31ccbcd0204c3612986a6bc20d57ed6825e9c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-05 | 172 | 106 | 5 | 2a4614b3d25e8c6b095e6992d8ca35371dcdb5e1 | |
| ToppCell | control-Lymphocytic-B_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.87e-05 | 173 | 106 | 5 | 95af11b7d6c7dcd470943e5bdc56bed7a134e358 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.04e-05 | 174 | 106 | 5 | 59ccc5a82507463e0a316ba6286cb25ec1a4091b | |
| ToppCell | facs-Heart-RV-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-05 | 176 | 106 | 5 | fb3d03f64592e1df1d9785d9f2e70938d7ff9ce8 | |
| ToppCell | facs-Heart-RV-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-05 | 176 | 106 | 5 | 99410c121f55adbc7fcc013c8fa8905a45dba76b | |
| ToppCell | COVID-19_Moderate-B_intermediate|COVID-19_Moderate / disease group, cell group and cell class | 6.55e-05 | 177 | 106 | 5 | 68e3d12a0c048a2d0f1b9680c7338a35855bba30 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 6.90e-05 | 179 | 106 | 5 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-erythroid-early_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.90e-05 | 179 | 106 | 5 | 3f73f89905c061ada4e3eb921fa394d95f95c959 | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 6.90e-05 | 179 | 106 | 5 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | COVID-19_Moderate-B_intermediate|World / disease group, cell group and cell class | 7.09e-05 | 180 | 106 | 5 | bd81b87a6dc81e5ab4a6c948eb0c80f14401a6a7 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 181 | 106 | 5 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | COVID-19-lung-Epithelial|lung / Disease (COVID-19 only), tissue and cell type | 7.27e-05 | 181 | 106 | 5 | 8298ed2a8b34d018c3665c68f4aa42fc4c2777d5 | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 7.27e-05 | 181 | 106 | 5 | 9cd5e5c285c2b628db9d59709af053defd7c0aff | |
| ToppCell | critical-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.27e-05 | 181 | 106 | 5 | f0d81ae74d3f32979624a94b2ef93774831a7970 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 182 | 106 | 5 | dc55de945c6f78f32eb3a1b3520835eb8417e068 | |
| ToppCell | E15.5-Endothelial-large_vessel_endothelial_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.47e-05 | 182 | 106 | 5 | 345d0f9d5ee30434bc2aac17608ccdc9e61c8fa3 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 182 | 106 | 5 | 010a7364da46101cb5068891fd7bc712ea8f13bd | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 182 | 106 | 5 | b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.66e-05 | 183 | 106 | 5 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-05 | 183 | 106 | 5 | 877559962b2b073fc2a9f1b64a76e17895e40a97 | |
| ToppCell | COVID-19-lung-Epithelial|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.66e-05 | 183 | 106 | 5 | 3a5d00006a195b5a5c27e7ace615e5de73145e97 | |
| ToppCell | IPF-Epithelial-ATI|IPF / Disease state, Lineage and Cell class | 7.66e-05 | 183 | 106 | 5 | c0a3541c45bd0c587603521f392f42dd86c3c35b | |
| ToppCell | (7)_Epithelial-H_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.86e-05 | 184 | 106 | 5 | 1f76b37c265b519171b767a52d48f31f0cdc4a3c | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 7.86e-05 | 184 | 106 | 5 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 7.86e-05 | 184 | 106 | 5 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.86e-05 | 184 | 106 | 5 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-05 | 185 | 106 | 5 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-05 | 186 | 106 | 5 | 9d6cb36aa0aae69fe584dad31deafcfdcc9fd1db | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-05 | 186 | 106 | 5 | 5d0cd07b6b51e8ce9e1da949f757dc4575ec5752 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-05 | 186 | 106 | 5 | 393f00ea6b434d4c8854dd8070d176579b71cd3b | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-DC1|Liver / Manually curated celltypes from each tissue | 8.27e-05 | 186 | 106 | 5 | e823529ffd06352c6bdec102f221fdf27f7c7369 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.48e-05 | 187 | 106 | 5 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.48e-05 | 187 | 106 | 5 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.48e-05 | 187 | 106 | 5 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.70e-05 | 188 | 106 | 5 | 5eb107122064f0a99dfd445cc87d3766f7257216 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.70e-05 | 188 | 106 | 5 | 524d1d928c9386acf20e53d31894107dd7290dc7 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-05 | 188 | 106 | 5 | 0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559 | |
| ToppCell | Endothelial-Endothelial-E|Endothelial / shred on cell class and cell subclass (v4) | 8.70e-05 | 188 | 106 | 5 | 2777eb7689b271c199021fe7d9db88ccebff14de | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.70e-05 | 188 | 106 | 5 | 1b57995d70cf81212e8d46dfaf44dbaf9c7bc4d5 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.70e-05 | 188 | 106 | 5 | cd2d1f8e43c252dd8730a5758458ef63e7ffc836 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.70e-05 | 188 | 106 | 5 | f5a2f324f3f6c5078d57130392d3f1ba74f29094 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.70e-05 | 188 | 106 | 5 | bba6b273bd47dd0e27fde914e9e6fc9d76fd5176 | |
| ToppCell | 5'-Airway_Nasal-Endothelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.70e-05 | 188 | 106 | 5 | 6c9d5e4014f807149328ff4eabd5e86dfe18094d | |
| ToppCell | Healthy-B_naive|World / disease group, cell group and cell class | 8.92e-05 | 189 | 106 | 5 | 1e533a43f739ff295740cf2b25479756dfb8e595 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.92e-05 | 189 | 106 | 5 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.92e-05 | 189 | 106 | 5 | 16e019fd6e2376110b767739754389891f391669 | |
| ToppCell | 10x5'-blood-Lymphocytic_B-Memory_B_cells|blood / Manually curated celltypes from each tissue | 8.92e-05 | 189 | 106 | 5 | 8aa65ffc396ccc5e86a6d38b99a2d51c34c9b6d2 | |
| Drug | NSC95090 | 5.96e-10 | 40 | 105 | 7 | CID000003251 | |
| Drug | dibenamine | 1.78e-09 | 26 | 105 | 6 | CID000005820 | |
| Drug | 3-hydroxy-4-methoxycinnamic acid | 3.67e-09 | 14 | 105 | 5 | CID000092126 | |
| Drug | phenylpropanolamine | 5.58e-09 | 31 | 105 | 6 | CID000004786 | |
| Drug | Br-pindolol | 6.36e-09 | 6 | 105 | 4 | CID000125847 | |
| Drug | thymoxamine | 1.55e-08 | 18 | 105 | 5 | CID000004260 | |
| Drug | pirbuterol | 2.95e-08 | 8 | 105 | 4 | CID000004845 | |
| Drug | Octopamine | 2.95e-08 | 8 | 105 | 4 | ctd:D009655 | |
| Drug | alph a- | 3.09e-08 | 69 | 105 | 7 | CID000234384 | |
| Drug | BMY 7378 | 3.28e-08 | 41 | 105 | 6 | CID000002419 | |
| Drug | spiroxatrine | 3.82e-08 | 42 | 105 | 6 | CID000005268 | |
| Drug | iodoLSD | 5.29e-08 | 9 | 105 | 4 | CID000151142 | |
| Drug | dapiprazole | 5.29e-08 | 9 | 105 | 4 | CID003033538 | |
| Drug | Norepinephrine | 8.78e-08 | 10 | 105 | 4 | DB00368 | |
| Drug | L-659,066 | 8.78e-08 | 10 | 105 | 4 | CID000163952 | |
| Drug | Droxidopa | 8.78e-08 | 10 | 105 | 4 | DB06262 | |
| Drug | DO 710 | 8.78e-08 | 10 | 105 | 4 | CID003084985 | |
| Drug | arbutamine | 9.53e-08 | 3 | 105 | 3 | ctd:C076559 | |
| Drug | N-(3-hydroxy-1-(naphthalen-1-yl)-1,8,11-trioxa-5-azatridecan-13-yl)-6-(2-(2-(4,4-difluoro-4,4a-dihydro-5-(thiophen-2-yl)-4-bora-3a,4a-diaza-s-indacene-3-yl)vinyl)phenoxyacetamido)hexanamide | 9.53e-08 | 3 | 105 | 3 | ctd:C568515 | |
| Drug | 3-iodopindolol | 9.53e-08 | 3 | 105 | 3 | CID000123825 | |
| Drug | p-azidobenzylcarazolol | 9.53e-08 | 3 | 105 | 3 | CID000133262 | |
| Drug | Fenoterol | 9.53e-08 | 3 | 105 | 3 | DB01288 | |
| Drug | LCB 2183 | 9.53e-08 | 3 | 105 | 3 | CID000133046 | |
| Drug | U-43,465F | 9.53e-08 | 3 | 105 | 3 | CID000134388 | |
| Drug | Arbutamine | 9.53e-08 | 3 | 105 | 3 | DB01102 | |
| Drug | broxaterol | 9.53e-08 | 3 | 105 | 3 | ctd:C045916 | |
| Drug | pBABC | 9.53e-08 | 3 | 105 | 3 | CID000126676 | |
| Drug | EXP063 | 9.53e-08 | 3 | 105 | 3 | CID003037493 | |
| Drug | ICYP-azide-2 | 9.53e-08 | 3 | 105 | 3 | CID003036190 | |
| Drug | BAM-CYP | 9.53e-08 | 3 | 105 | 3 | CID000125252 | |
| Drug | butofilolol | 9.53e-08 | 3 | 105 | 3 | CID000068838 | |
| Drug | soquinolol | 9.53e-08 | 3 | 105 | 3 | CID000068811 | |
| Drug | CS 476 | 9.53e-08 | 3 | 105 | 3 | CID000100459 | |
| Drug | exaprolol | 9.53e-08 | 3 | 105 | 3 | CID000065484 | |
| Drug | AHR-9377 | 9.53e-08 | 3 | 105 | 3 | CID000054961 | |
| Drug | dicyclopropyl ketoxime | 9.53e-08 | 3 | 105 | 3 | CID000015072 | |
| Drug | Oberadilol | 9.53e-08 | 3 | 105 | 3 | CID003047798 | |
| Drug | CGP-12177-NBD | 9.53e-08 | 3 | 105 | 3 | CID003081105 | |
| Drug | Bupranolol | 9.53e-08 | 3 | 105 | 3 | DB08808 | |
| Drug | p-azidoclonidine | 9.53e-08 | 3 | 105 | 3 | CID003035819 | |
| Drug | ICYP-azide-1 | 9.53e-08 | 3 | 105 | 3 | CID000133837 | |
| Drug | AC1L4W2Z | 9.53e-08 | 3 | 105 | 3 | CID000193350 | |
| Drug | H 216/44 | 9.53e-08 | 3 | 105 | 3 | CID000130141 | |
| Drug | AC1L1TT8 | 9.53e-08 | 3 | 105 | 3 | CID000060729 | |
| Drug | ADATN | 9.53e-08 | 3 | 105 | 3 | CID000133861 | |
| Drug | CH-38083 | 1.37e-07 | 11 | 105 | 4 | CID000123716 | |
| Drug | mianserin | 1.56e-07 | 87 | 105 | 7 | CID000004184 | |
| Drug | iprindole | 1.71e-07 | 28 | 105 | 5 | CID000021722 | |
| Drug | mirtazapine | 1.80e-07 | 54 | 105 | 6 | CID000004205 | |
| Drug | SZL-49 | 2.05e-07 | 12 | 105 | 4 | CID000004892 | |
| Drug | Ephedra | 2.05e-07 | 12 | 105 | 4 | DB01363 | |
| Drug | 5-methylurapidil | 2.06e-07 | 29 | 105 | 5 | CID000005640 | |
| Drug | cyanopindolol | 2.50e-07 | 57 | 105 | 6 | CID000155346 | |
| Drug | indoramin | 2.96e-07 | 13 | 105 | 4 | CID000033625 | |
| Drug | 1-ephedrine | 3.08e-07 | 59 | 105 | 6 | CID000005032 | |
| Drug | ritanserin | 3.76e-07 | 61 | 105 | 6 | CID000005074 | |
| Drug | v315 | 3.80e-07 | 4 | 105 | 3 | CID000053925 | |
| Drug | NHNPNBE | 3.80e-07 | 4 | 105 | 3 | CID006453817 | |
| Drug | eclanamine | 3.80e-07 | 4 | 105 | 3 | CID000051228 | |
| Drug | Tobanum | 3.80e-07 | 4 | 105 | 3 | CID000065814 | |
| Drug | flestolol | 3.80e-07 | 4 | 105 | 3 | CID000055884 | |
| Drug | DAPN | 3.80e-07 | 4 | 105 | 3 | CID000125184 | |
| Drug | SOM-1122 | 3.80e-07 | 4 | 105 | 3 | CID000068918 | |
| Drug | tienoxolol | 3.80e-07 | 4 | 105 | 3 | CID000065678 | |
| Drug | Alp-NBD | 3.80e-07 | 4 | 105 | 3 | CID000126953 | |
| Drug | i 583 | 3.80e-07 | 4 | 105 | 3 | CID000072881 | |
| Drug | cyanopindolol | 3.80e-07 | 4 | 105 | 3 | ctd:C047975 | |
| Drug | acebutolol azide | 3.80e-07 | 4 | 105 | 3 | CID000133410 | |
| Drug | CGP 20712A | 3.80e-07 | 4 | 105 | 3 | ctd:C049763 | |
| Drug | iodoazidobenzylpindolol | 3.80e-07 | 4 | 105 | 3 | CID000132676 | |
| Drug | A61603 | 4.06e-07 | 33 | 105 | 5 | CID004038180 | |
| Drug | deriglidole | 4.13e-07 | 14 | 105 | 4 | CID000065945 | |
| Drug | MK-912 | 4.13e-07 | 14 | 105 | 4 | CID000123679 | |
| Drug | pindolol | 4.57e-07 | 63 | 105 | 6 | CID000004828 | |
| Drug | urapidil | 4.74e-07 | 34 | 105 | 5 | CID000005639 | |
| Drug | phendioxan | 5.51e-07 | 35 | 105 | 5 | CID000185453 | |
| Drug | S-(-)-Lisuride | 5.52e-07 | 65 | 105 | 6 | CID000003938 | |
| Drug | SKF 104078 | 5.61e-07 | 15 | 105 | 4 | CID000122295 | |
| Drug | amosulalol | 5.61e-07 | 15 | 105 | 4 | CID000002169 | |
| Drug | HV723 | 5.61e-07 | 15 | 105 | 4 | CID003081094 | |
| Drug | bisoprolol | 7.35e-07 | 37 | 105 | 5 | CID000002405 | |
| Drug | fluparoxan | 7.45e-07 | 16 | 105 | 4 | CID000072036 | |
| Drug | guanethidine | 9.38e-07 | 113 | 105 | 7 | CID000003518 | |
| Drug | HHCA | 9.47e-07 | 5 | 105 | 3 | CID009576894 | |
| Drug | Propranolol | 9.47e-07 | 5 | 105 | 3 | DB00571 | |
| Drug | oxyfedrine | 9.47e-07 | 5 | 105 | 3 | CID000027454 | |
| Drug | Clenbuterol | 9.47e-07 | 5 | 105 | 3 | DB01407 | |
| Drug | AC1Q7AC1 | 9.47e-07 | 5 | 105 | 3 | CID000122310 | |
| Drug | fluorocarazolol | 9.47e-07 | 5 | 105 | 3 | CID000133038 | |
| Drug | S 9871 | 9.47e-07 | 5 | 105 | 3 | CID003036124 | |
| Drug | 6-Hdpei | 9.47e-07 | 5 | 105 | 3 | CID000137395 | |
| Drug | DJ-7141 | 9.47e-07 | 5 | 105 | 3 | CID000174123 | |
| Drug | 2,6-DMC | 9.47e-07 | 5 | 105 | 3 | CID000078576 | |
| Drug | NF503 | 9.47e-07 | 5 | 105 | 3 | CID005311251 | |
| Drug | MPV-2426 | 9.47e-07 | 5 | 105 | 3 | CID006433097 | |
| Drug | Bopindolol | 9.47e-07 | 5 | 105 | 3 | DB08807 | |
| Drug | NA--can | 9.47e-07 | 5 | 105 | 3 | CID000007387 | |
| Drug | sibenadet | 9.47e-07 | 5 | 105 | 3 | CID000183811 | |
| Drug | pafenolol | 9.47e-07 | 5 | 105 | 3 | CID000071144 | |
| Drug | lidamidine | 9.47e-07 | 5 | 105 | 3 | CID000047509 | |
| Disease | acute pancreatitis | 3.06e-05 | 18 | 101 | 3 | EFO_1000652 | |
| Disease | tubulointerstitial nephritis antigen-like measurement | 3.47e-05 | 3 | 101 | 2 | EFO_0803197 | |
| Disease | polycystic ovary syndrome (biomarker_via_orthology) | 4.95e-05 | 21 | 101 | 3 | DOID:11612 (biomarker_via_orthology) | |
| Disease | hypertension (is_implicated_in) | 6.17e-05 | 121 | 101 | 5 | DOID:10763 (is_implicated_in) | |
| Disease | cystic fibrosis (is_marker_for) | 6.19e-05 | 62 | 101 | 4 | DOID:1485 (is_marker_for) | |
| Disease | migraine (implicated_via_orthology) | 6.93e-05 | 4 | 101 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | triacylglycerol 50:1 measurement | 1.07e-04 | 27 | 101 | 3 | EFO_0010408 | |
| Disease | amino acid measurement | GCKR CLDN23 PTH2R SLC6A2 PLA2R1 ADRA1D PTPRB ACAD11 RXFP2 SLC6A5 | 1.13e-04 | 678 | 101 | 10 | EFO_0005134 |
| Disease | Asthma | 1.67e-04 | 80 | 101 | 4 | C0004096 | |
| Disease | disease of metabolism (is_implicated_in) | 1.72e-04 | 6 | 101 | 2 | DOID:0014667 (is_implicated_in) | |
| Disease | childhood absence epilepsy (implicated_via_orthology) | 1.72e-04 | 6 | 101 | 2 | DOID:1825 (implicated_via_orthology) | |
| Disease | Dystonia | 2.21e-04 | 86 | 101 | 4 | C0013421 | |
| Disease | X-18899 measurement | 2.41e-04 | 7 | 101 | 2 | EFO_0800793 | |
| Disease | Mood Disorders | 2.87e-04 | 168 | 101 | 5 | C0525045 | |
| Disease | X-24748 measurement | 3.20e-04 | 8 | 101 | 2 | EFO_0022136 | |
| Disease | urticaria (is_implicated_in) | 3.20e-04 | 8 | 101 | 2 | DOID:1555 (is_implicated_in) | |
| Disease | myasthenia gravis (is_implicated_in) | 3.20e-04 | 8 | 101 | 2 | DOID:437 (is_implicated_in) | |
| Disease | Alcoholic Intoxication, Chronic | 3.27e-04 | 268 | 101 | 6 | C0001973 | |
| Disease | congestive heart failure (implicated_via_orthology) | 3.78e-04 | 41 | 101 | 3 | DOID:6000 (implicated_via_orthology) | |
| Disease | end stage renal disease (is_implicated_in) | 3.78e-04 | 41 | 101 | 3 | DOID:783 (is_implicated_in) | |
| Disease | BRCA2 mutation carier statu | 5.13e-04 | 10 | 101 | 2 | EFO_0011022 | |
| Disease | level of Ceramide (d40:1) in blood serum | 6.25e-04 | 11 | 101 | 2 | OBA_2045185 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 7.19e-04 | 51 | 101 | 3 | EFO_0022302 | |
| Disease | abdominal aortic aneurysm (is_implicated_in) | 7.49e-04 | 12 | 101 | 2 | DOID:7693 (is_implicated_in) | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 8.51e-04 | 54 | 101 | 3 | EFO_0022244 | |
| Disease | celiac disease | 9.40e-04 | 126 | 101 | 4 | EFO_0001060 | |
| Disease | Bipolar Disorder | 1.29e-03 | 477 | 101 | 7 | C0005586 | |
| Disease | chronic obstructive pulmonary disease (is_implicated_in) | 1.33e-03 | 63 | 101 | 3 | DOID:3083 (is_implicated_in) | |
| Disease | Tremor, Rubral | 1.35e-03 | 16 | 101 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 1.35e-03 | 16 | 101 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 1.35e-03 | 16 | 101 | 2 | C0278161 | |
| Disease | Ataxia, Sensory | 1.35e-03 | 16 | 101 | 2 | C0240991 | |
| Disease | phosphatidylcholine 32:2 measurement | 1.35e-03 | 16 | 101 | 2 | EFO_0010374 | |
| Disease | Abnormal coordination | 1.35e-03 | 16 | 101 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 1.35e-03 | 16 | 101 | 2 | C0427190 | |
| Disease | Lipidemias | 1.53e-03 | 17 | 101 | 2 | C1706412 | |
| Disease | Moyamoya Disease | 1.53e-03 | 17 | 101 | 2 | C0026654 | |
| Disease | Hyperlipidemia | 1.53e-03 | 17 | 101 | 2 | C0020473 | |
| Disease | age at onset, Myopia | 1.79e-03 | 150 | 101 | 4 | EFO_0004847, HP_0000545 | |
| Disease | X-24309 measurement | 2.12e-03 | 20 | 101 | 2 | EFO_0800872 | |
| Disease | cortical surface area measurement | MON2 CACNA1A SAMD9 LAMA2 CPA3 ATP13A2 CLDN23 ARF1 ACAD11 TJP1 CCR4 HSD17B3 | 2.16e-03 | 1345 | 101 | 12 | EFO_0010736 |
| Disease | interleukin-2 receptor subunit alpha measurement | 2.33e-03 | 21 | 101 | 2 | EFO_0010587 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 2.46e-03 | 78 | 101 | 3 | EFO_0022187 | |
| Disease | Lung diseases | 2.46e-03 | 78 | 101 | 3 | C0024115 | |
| Disease | alkaline phosphatase measurement | HSPG2 SEMA4B SAMD9 HLA-DRB1 GPRC5C GCKR CPT1A CLDN23 EDEM1 RIC1 | 2.53e-03 | 1015 | 101 | 10 | EFO_0004533 |
| Disease | phosphatidylcholine 34:3 measurement | 2.56e-03 | 22 | 101 | 2 | EFO_0010377 | |
| Disease | Bronchiectasis | 2.56e-03 | 22 | 101 | 2 | C0006267 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.63e-03 | 276 | 101 | 5 | EFO_0004612, EFO_0020943 | |
| Disease | S-7-hydroxywarfarin to S-warfarin ratio measurement | 2.74e-03 | 81 | 101 | 3 | EFO_0803334 | |
| Disease | primary open angle glaucoma (is_implicated_in) | 2.80e-03 | 23 | 101 | 2 | DOID:1070 (is_implicated_in) | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 3.24e-03 | 86 | 101 | 3 | EFO_0008595, EFO_0020945 | |
| Disease | arachidonic acid measurement | 3.31e-03 | 25 | 101 | 2 | EFO_0006808 | |
| Disease | Ataxia | 3.31e-03 | 25 | 101 | 2 | C0004134 | |
| Disease | aggressive behavior | 3.31e-03 | 25 | 101 | 2 | EFO_0003015 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NWLYFIPLIIIGSFF | 336 | O00555 | |
| FFNWLGYANSAFNPI | 361 | P08588 | |
| LNWIGYVNSGFNPLI | 311 | P07550 | |
| VFFLIPYLDIWNIHG | 16 | Q7Z6A9 | |
| PLWRHYFQNTQGLIF | 76 | P84085 | |
| AQDFAVGLGPRLQWY | 206 | P50416 | |
| AFLLGGILYSWQFPH | 311 | Q12887 | |
| PLWRHYFQNTQGLIF | 76 | P61204 | |
| NARYEFGPALFVGWA | 156 | Q8N6F1 | |
| LELLRQFDLAWQYGP | 46 | Q9HCU8 | |
| FLGFWTPYNIVLFLE | 251 | P51679 | |
| TGQPLYEGWFLALFN | 1021 | O60423 | |
| LNWLGYANSAFNPLI | 331 | P13945 | |
| PPDYNFSEQFWFLLA | 686 | A1A5B4 | |
| ILPNWNFFLALSYFK | 301 | Q709F0 | |
| ANGWVFLLAYVSPEF | 251 | Q8NFJ5 | |
| NFAQLGHESFYWQLP | 1386 | P98160 | |
| ALWNYLFAAVGNPKD | 911 | Q4ADV7 | |
| FFFNLAGILLWYLVP | 451 | Q8N130 | |
| THQQWYLFNDFLIEP | 886 | Q504Q3 | |
| ELSWYNIFLYNPDGN | 1111 | P23467 | |
| DFLLVGLFQYGWINS | 26 | Q8NG84 | |
| QGYANPFWLALALLI | 206 | Q96NT5 | |
| LGSVVGNWQYFFPVI | 136 | P43357 | |
| LGSVVGNWQYFFPVI | 136 | P43360 | |
| WNYPLFQDLNGQSLF | 76 | Q9NPP4 | |
| RFPNFSILYWLGNGS | 91 | O95998 | |
| VTLQGFVGPWYRNLF | 396 | O43861 | |
| PLWILGDVFIRQFYS | 366 | P14091 | |
| FWGLEIIHFNNPEYQ | 86 | Q9H3M9 | |
| DAALYWPLNQKVFLF | 381 | Q99542 | |
| FPVYQGSTDILFLWN | 496 | Q8TET4 | |
| WGDQDLLNIIFYFNP | 311 | A0PJZ3 | |
| IFDFLGYQWAPILAN | 26 | Q5VXU1 | |
| AFPLLFGIFNLVYWA | 426 | P14867 | |
| TYFDNKPIGLWNFRE | 2306 | P24043 | |
| FAPAEWVALNYVPFA | 1396 | Q7Z3U7 | |
| DFFILLGFSNWPQLE | 11 | O76002 | |
| PNLWIIGAAVVNAFY | 561 | Q495T6 | |
| WPLLFFEYEGNFIQK | 461 | Q14397 | |
| ANAWAFVLFYVIPEV | 286 | Q9NQ84 | |
| ALQNAFGDRWGPYFA | 756 | Q7Z3G6 | |
| QLGGYFLTLAQPWFV | 1016 | Q9NQ11 | |
| GPAQQNFEWFLYRPE | 56 | Q969P0 | |
| LENYLANLFAGAWEP | 241 | A1L0T0 | |
| NFYILPVFNVDGYIW | 211 | P15088 | |
| IADLRNAFYVLFPIW | 36 | P35575 | |
| NAFYVLFPIWFHLQE | 41 | P35575 | |
| EGLQTFFVLQWIPVY | 11 | Q6ZPD8 | |
| FFVLQWIPVYIFLGA | 16 | Q6ZPD8 | |
| FYPGSIEVRWFLNGQ | 151 | P01911 | |
| NFPAVLSLFLLYGWS | 1871 | Q9BZC7 | |
| AFLWLGYINSGLNPF | 296 | Q13639 | |
| PLWRHYFQNTQGLIF | 76 | P84077 | |
| YNWQLQAPDVLFYPL | 476 | Q92611 | |
| HPLWFGQFIGFLNIY | 81 | P13584 | |
| LVYLHQAGWFPFRQE | 311 | Q9BSE4 | |
| FNIGLLWVPYIKEQF | 176 | O60931 | |
| IPAWAFYSGAFQRLL | 281 | P37058 | |
| FLNQPVDVELYQGLW | 36 | Q96B33 | |
| ENWLQYFPLSQILFV | 341 | Q9Y661 | |
| EYLELFARNLQPGWT | 436 | Q8N3J2 | |
| QGYALFVFSLGPIWD | 2111 | A6NMZ7 | |
| FGALGWNIPYEFNQA | 4201 | Q8TE73 | |
| WLFYGDQLGLAPQVL | 296 | Q5HYA8 | |
| IAVLQSNLWPGAYAF | 621 | Q5TD94 | |
| AFPYNPVLQFLAFQW | 86 | P59551 | |
| PVLQFLAFQWDFLNA | 91 | P59551 | |
| GFAVDLANVWRFPYL | 71 | P23975 | |
| WLRAAGFPQYAQLYE | 66 | Q9Y3M8 | |
| LLPWNFFITAIPYFQ | 26 | Q14542 | |
| FLAFILGNVYFWLQL | 121 | A6NC51 | |
| LGNVWRFPYLAFQNG | 211 | Q9Y345 | |
| GWEPFTQLFAEYQTL | 841 | A6NFQ2 | |
| WPQLPNGLEAAYEFA | 321 | P03956 | |
| LFGYWLLCFVLPATN | 136 | O95255 | |
| PYFLASLLFWPENQQ | 1431 | Q5K651 | |
| QPWNYFNIFSRILGG | 41 | Q7RTZ1 | |
| NLSFLPGGEYQELLW | 96 | Q9NPR2 | |
| LIAVIPFWNKDYFGN | 551 | Q8WXD0 | |
| YLWPAVQLANFYLVP | 136 | P39210 | |
| ALERQIFDFLGYQWA | 21 | Q4KMZ8 | |
| IFDFLGYQWAPILAN | 26 | Q4KMZ8 | |
| FYRLIPQPAFQWAFE | 296 | Q15477 | |
| QGLEHPFLVNLWYSF | 76 | Q8WU08 | |
| FWNVFAYDLLGAHIP | 421 | O75783 | |
| WQNRYFVLDFEAGIL | 91 | Q9BXB5 | |
| LNYLNWSPEVNFEPF | 311 | Q13018 | |
| WLGYANSLINPFIYA | 371 | P34969 | |
| VIFWLGYFNSCVNPL | 386 | P25100 | |
| ALERQVFDFLGYQWA | 21 | Q8IVV8 | |
| VFDFLGYQWAPILAN | 26 | Q8IVV8 | |
| FQFLLLDTPAQLWYF | 201 | Q92759 | |
| GQPFWLTLHFEGRNY | 36 | P21980 | |
| LNYTQWFPIVIFFNP | 801 | Q9UDY2 | |
| AGLPSWQYQRIHFFL | 196 | A6NNV3 | |
| AGLPSWQYQRIHFFL | 236 | P0DV79 | |
| AGLPSWQYQRIHFFL | 236 | A0A494C086 | |
| NAFLVAPQIYWFCLL | 226 | Q8TBR7 | |
| AIWDGYLQQADPFFI | 216 | Q9NUY8 | |
| GASFNDNIIKWLYFP | 1201 | Q9H5I5 | |
| WAALLVLFPYGAQGN | 16 | Q9UBV4 | |
| WLNEPNFVAAYDIGL | 281 | Q9P283 | |
| LYQDPRNVWGFLAAT | 56 | Q9NUH8 | |
| LAASQLQYYVPRGFW | 1656 | O00507 | |
| FATLIREWPGDLYNN | 476 | P49754 | |
| WIYQAPILAAIGLNF | 316 | P49190 | |
| QYALAGGISFPFFWL | 131 | Q9UI14 | |
| LNYAQWYPIVVFLNP | 716 | Q07157 | |
| LGAALLLAPQLYWFF | 236 | Q71RH2 | |
| KGVFNLLWAPDVYNL | 381 | Q5TAH2 | |
| AGLPSWQYQRIHFFL | 196 | A6NJR5 | |
| QGLEHPFLVNLWYSF | 76 | Q9NY57 | |
| ERPLVAAQFLWNALY | 51 | Q6GMV2 | |
| LFWYQQALGQGPEFL | 51 | A0A1B0GX51 |